Explaining the Basics: What is the BOJ's Large-Scale Monetary Easing, Aimed at 2% Inflation for 11 Years?
We haven't written up this one. Asahi Business has the full story — the link below goes straight to it.
More in Business
Real Estate: Frankfurt's Commuter Belt – Buying Still Pays Off for Commuters
Prices in the surrounding area are rising, but the gap with the main metropolis remains large. An exclusive ranking shows where buyers are at an advantage despite travel costs and where they quickly…
PTI leaders barred from entertaining any move to replace Afridi
ISLAMABAD: Pakistan Tehreek-e-Insaf (PTI) chairman Barrister Gohar Ali Khan on Thursday barred party leaders from entertaining any move to replace Khyber Pakhtunkhwa Chief Minister Sohail Afridi…
Pakistani traders: Proposal for 1 year multiple-entry visas to be considered: BD envoy
KARACHI: Deputy High Commissioner of Bangladesh Sakib Sadakat has said his country is keen to promote bilateral trade with Pakistan and further strengthen mutual ties.
APR Surpasses Full-Year 2025 Results in 9 Months as Overseas Sales Hit 94%
APR surpassed its full-year 2025 revenue and operating profit in just nine months, driven by rapid overseas expansion that propelled the South Korean beauty company to record quarterly revenue.
Paris Baguette Opens Store at Manila Airport
Paris Baguette has opened its second airport store at Ninoy Aquino International Airport (NAIA) in Manila, the Philippines’ largest gateway.
- Paris Baguette opens second store at Manila Airport, bringing total to nine locations.
- Store located in Terminal 2, targeting domestic flights by major airlines.
- 24-hour operation with diverse menu to cater to airport travelers' needs.
GC Biopharma, Hanmi Seal Fabry Drug Deal
A collaboration between two leading South Korean pharmaceutical companies has resulted in a global technology export deal worth 630 billion won ($475.00 million).
- GC Biopharma and Hanmi Pharmaceutical form $475M deal for Fabry drug LA-GLA
- Exclusive license grants $70M upfront to partners, with potential $405M in milestone payments
- Preclinical trials show improved kidney function, blood vessels, and nervous system in LA-GLA